BSE filing, NSE: ALPA. Summary written from the filing by ALFA Finder's alert engine.
Alpa Laboratories Ltd: key numbers
- Share price
- ₹52.20
- Market cap
- ₹109.8 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹15.01 Cr
- P/E (TTM)
- 31.4×Sector 46.1×
- Promoter holding
- 57.19%+0.00% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alpa Laboratories Ltd
All →Alpa Laboratories Other Announcement
Alpa Laboratories Ltd has submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI Listing Regulations for the period ended September 30, 2026.
Alpa Laboratories Annual General Meeting
Alpa Laboratories shareholders approved seven resolutions at the AGM, including a Rs. 160 Crore limit for loans and investments. All ordinary and special resolutions were passed.
- Value
- ₹160.0 Cr
Alpa Laboratories Annual General Meeting
Alpa Laboratories Ltd. held its 38th AGM on September 30, 2026. Shareholders approved financial statements, director appointments, auditor remuneration, and investment limits under Section 186.
Alpa Laboratories Management Change
Alpa Laboratories Ltd has appointed Ms. Diksha Jaswani as the Company Secretary and Compliance Officer (KMP), effective September 17, 2026.
Alpa Laboratories Annual Report
Alpa Laboratories Ltd. has submitted its Annual Report for FY 2025-26 and the Notice for its 38th Annual General Meeting scheduled for September 30, 2026.
Alpa Laboratories Management Change
Alpa Laboratories appointed Mrs. Radhika Biyani as an Additional Independent Director, effective 5 September 2026. Board committees were reconstituted following the change.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.